Aidite 2026H1: Revenue of RMB 582 million, up approximately 20% YoY, with oral digital equipment income surging over 40%.

Source: Aidite 2026 Semi-Annual Report

Net Profit Attributable to Shareholders of the Parent Company +13.55% YoY / Digital Equipment Revenue +41.81% YoY / R&D Investment +54.66% YoY

DentalGoodNews｜On August 25, 2026, Aidite (Qinhuangdao) Technology Co., Ltd. (hereinafter referred to as "Aidite") released its 2026 semi-annual report. The report shows that the company achieved operating revenue of RMB 582 million in the first half of the year, a year-on-year increase of 19.75%; net profit attributable to shareholders of the listed company was RMB 105 million, up 13.55% year-on-year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 92 million, up 9.12% year-on-year. The company's basic earnings per share were RMB 0.70, and the weighted average return on equity was 4.77%, an increase of 0.23 percentage points compared with the same period last year.

Source: Aidite 2026 Semi-Annual Report

In terms of product structure, dental restoration materials achieved revenue of RMB 407 million in the first half of the year, up 13.57% year-on-year, with a gross margin of 60.43%, an increase of 2.23 percentage points compared with the same period last year. Dental digital equipment achieved revenue of RMB 136 million, up 41.81% year-on-year, with a gross margin of 38.05%, an increase of 7.55 percentage points compared with the same period last year. In the report, the company cited digital product iteration and upgrades, as well as increased global channel penetration, as background factors for the growth of related businesses.

During the reporting period, the company's overseas revenue was RMB 430 million, accounting for 73.85% of total revenue; domestic revenue was RMB 152 million, accounting for 26.15%. According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), Aidite's full-year revenue for 2025 was RMB 1.035 billion, with overseas market revenue accounting for 66.31%.

Source: Aidite 2026 Semi-Annual Report

In terms of R&D investment, Aidite's R&D expenditure in the first half of the year was RMB 43.6985 million, up 54.66% year-on-year, with the proportion of revenue rising to 7.51%. During the reporting period, the company carried out joint R&D collaborations with Peking University, Sichuan University, Sun Yat-sen University, Shanghai Jiao Tong University, South China University of Technology, as well as West China Hospital of Stomatology, the Affiliated Stomatology Hospital of Sun Yat-sen University, and Peking University School of Stomatology, advancing clinical validation and technology transfer in areas such as new biomimetic dental restoration materials and dental implantation.

In terms of financials, the company's net cash flow from operating activities in the first half of the year was RMB 37.7686 million, a year-on-year decrease of 52.28%, mainly due to increased cash payments for procurement driven by expanded operating revenue, as well as timing differences in tax rebates.

The company continues to advance the construction of the Aidite Dental Industry Park project, covering CAD/CAM material industrialization, a digital oral comprehensive service platform, and the China industrialization and R&D pilot base for the Wolland dental implant. In addition, through its shareholding in Jingdezhen Wanwei New Materials Co., Ltd., the company has strengthened its upstream self-supply capability for zirconia powder, forming an industrial chain synergy between upstream powder and downstream ceramic blocks.

The company also disclosed that for the reporting period, it will not distribute cash dividends, issue bonus shares, or convert capital reserve into share capital.